STOCK TITAN

[SCHEDULE 13G/A] Enbridge, Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

TL;DR: Revenue up on M&A, but earnings, margins and cash flow deteriorated; leverage now elevated—overall negative.

The 9% sales lift is acquisition-led; organic demand is lacklustre, particularly at CPI. Gross and operating margins compressed materially as SAT integration costs, amortisation and inflation offset pricing. EPS fell 40% and cash generation weakened, raising concerns about the sustainability of dividend growth and buybacks. Net leverage (≈2.8× EBITDA pro forma) rises after drawing £300 m of term debt; higher rates magnify interest costs. Without faster synergy capture or CPI volume recovery, valuation multiples could compress. I rate the quarter negative.

TL;DR: Strategic logic of DLR/OpSec solid, but integration drag will persist through 2025; payoff hinges on synergy execution.

DLR expands SAT’s portfolio and geographic reach; paying ~2.1× 2024 sales is sensible if projected synergies materialise. Non-controlling interest structure in Ghana adds complexity but offers emerging-market upside. Management expects $10-15 m of one-time integration cost—modest relative to deal size. However, immediate EPS dilution and debt load highlight execution risk. If SAT realises cross-selling potential and CPI stabilises, CXT could regain double-digit EPS growth from 2026. Near-term view is neutral-to-cautiously positive.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentages used herein are calculated based upon 16,000,000 Preferred shares outstanding as of June 4.,2025 as sourced from Bloomberg


SCHEDULE 13G



Picton Mahoney Asset Management
Signature:Catrina Duong
Name/Title:General Counsel and Chief Compliance Officer
Date:08/06/2025

Comments accompanying signature: After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Enbridge

NYSE:ENB

ENB Rankings

ENB Latest News

ENB Latest SEC Filings

ENB Stock Data

101.92B
2.18B
0.14%
54.59%
1.53%
Oil & Gas Midstream
Pipe Lines (no Natural Gas)
Link
Canada
CALGARY